Sue Leurgans to Movement
This is a "connection" page, showing publications Sue Leurgans has written about Movement.
Connection Strength
0.732
-
Spinal motor neurons and motor function in older adults. J Neurol. 2019 Jan; 266(1):174-182.
Score: 0.150
-
Industrial wrist motions and incidence of hand/wrist cumulative trauma disorders. Ergonomics. 1994 Sep; 37(9):1449-59.
Score: 0.112
-
Resolving kinematic redundancy in target-reaching movements with and without external constraint. Exp Brain Res. 2008 Oct; 191(1):67-81.
Score: 0.074
-
Changes in the relationship between movement velocity and movement distance in primary focal hand dystonia. J Mot Behav. 2008 Jul; 40(4):301-13.
Score: 0.073
-
Rating scale for psychogenic movement disorders: scale development and clinimetric testing. Mov Disord. 2005 Dec; 20(12):1592-7.
Score: 0.061
-
Olanzapine and clozapine: comparative effects on motor function in hallucinating PD patients. Neurology. 2000 Sep 26; 55(6):789-94.
Score: 0.043
-
Different Combinations of Mobility Metrics Derived From a Wearable Sensor Are Associated With Distinct Health Outcomes in Older Adults. J Gerontol A Biol Sci Med Sci. 2020 05 22; 75(6):1176-1183.
Score: 0.042
-
Objective changes in motor function during placebo treatment in PD. Neurology. 2000 Feb 08; 54(3):710-4.
Score: 0.041
-
Two-year exercise program improves physical function in Parkinson's disease: the PRET-PD randomized clinical trial. Neurorehabil Neural Repair. 2015 Feb; 29(2):112-22.
Score: 0.028
-
The role of dynamic three-dimensional trunk motion in occupationally-related low back disorders. The effects of workplace factors, trunk position, and trunk motion characteristics on risk of injury. Spine (Phila Pa 1976). 1993 Apr; 18(5):617-28.
Score: 0.025
-
A two-year randomized controlled trial of progressive resistance exercise for Parkinson's disease. Mov Disord. 2013 Aug; 28(9):1230-40.
Score: 0.025
-
Reducing dosing frequency of carbidopa/levodopa: double-blind crossover study comparing twice-daily bilayer formulation of carbidopa/levodopa (IPX054) versus 4 daily doses of standard carbidopa/levodopa in stable Parkinson disease patients. Clin Neuropharmacol. 2009 Jul-Aug; 32(4):189-92.
Score: 0.020
-
Variability of EMG patterns: a potential neurophysiological marker of Parkinson's disease? Clin Neurophysiol. 2009 Feb; 120(2):390-7.
Score: 0.019
-
Cognitive and motor function in patients with Parkinson's disease with and without depression. Clin Neuropharmacol. 2000 Nov-Dec; 23(6):331-4.
Score: 0.011
-
Biomechanical risk factors for occupationally related low back disorders. Ergonomics. 1995 Feb; 38(2):377-410.
Score: 0.007